Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shames

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Journal of Magnetic Resonance Imaging : JMRI|October 27, 2004
MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancerAnda Preda, Viktor Novikov, Martina Möglich, et al.
Radiology|November 30, 1999
Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular and small-molecular contrast media--preliminary experienceA Gossmann, Y Okuhata, D M Shames, et al.
Academic Radiology|August 1, 1996
Definition of peritumoral vessels with contrast-enhanced magnetic resonance imaging: comparison of gadopentetate dimeglumine and a blood-pool macromolecular contrast mediumR C Brasch, H C Schwickert, T P Roberts, et al.
Radiology|March 29, 2008
Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in ratsHans-Juergen Raatschen, Gerhard H Simon, Yanjun Fu, et al.
Investigative Radiology|June 1, 1994
Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomasR C Brasch, D M Shames, F M Cohen, et al.
Magnetic Resonance in Medicine|April 27, 2001
Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathologyK Turetschek, E Floyd, D M Shames, et al.
Magnetic Resonance in Medicine|June 16, 2009
Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic miceBarbara Sennino, Hans-Juergen Raatschen, Michael F Wendland, et al.
Technology in Cancer Research & Treatment|July 24, 2004
Magnetic resonance imaging detects early changes in microvascular permeability in xenograft tumors after treatment with the matrix metalloprotease inhibitor PrinomastatMarlene Wiart, Laure S Fournier, Viktor Y Novikov, et al.
The American Journal of Cardiology|August 1, 1978
Thallium-201 myocardial perfusion scintigraphy to evaluate patients after coronary bypass surgeryB H Greenberg, R Hart, E H Botvinick, et al.
Investigative Radiology|May 21, 2005
The choice of region of interest measures in contrast-enhanced magnetic resonance image characterization of experimental breast tumorsAnda Preda, Karl Turetschek, Heike Daldrup, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Journal of Magnetic Resonance Imaging : JMRI|October 27, 2004
MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancerAnda Preda, Viktor Novikov, Martina Möglich, et al.
Radiology|November 30, 1999
Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular and small-molecular contrast media--preliminary experienceA Gossmann, Y Okuhata, D M Shames, et al.
Academic Radiology|August 1, 1996
Definition of peritumoral vessels with contrast-enhanced magnetic resonance imaging: comparison of gadopentetate dimeglumine and a blood-pool macromolecular contrast mediumR C Brasch, H C Schwickert, T P Roberts, et al.
Radiology|March 29, 2008
Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in ratsHans-Juergen Raatschen, Gerhard H Simon, Yanjun Fu, et al.
Investigative Radiology|June 1, 1994
Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomasR C Brasch, D M Shames, F M Cohen, et al.
Magnetic Resonance in Medicine|April 27, 2001
Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathologyK Turetschek, E Floyd, D M Shames, et al.
Magnetic Resonance in Medicine|June 16, 2009
Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic miceBarbara Sennino, Hans-Juergen Raatschen, Michael F Wendland, et al.
Technology in Cancer Research & Treatment|July 24, 2004
Magnetic resonance imaging detects early changes in microvascular permeability in xenograft tumors after treatment with the matrix metalloprotease inhibitor PrinomastatMarlene Wiart, Laure S Fournier, Viktor Y Novikov, et al.
The American Journal of Cardiology|August 1, 1978
Thallium-201 myocardial perfusion scintigraphy to evaluate patients after coronary bypass surgeryB H Greenberg, R Hart, E H Botvinick, et al.
Investigative Radiology|May 21, 2005
The choice of region of interest measures in contrast-enhanced magnetic resonance image characterization of experimental breast tumorsAnda Preda, Karl Turetschek, Heike Daldrup, et al.
Pageof 12